By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Merck & Co

MSD’s Phase III trial of head and neck cancer treatment meets primary endpoint Clinical Trials Arena11:40Cancer Treatment Pharma Cancer

Aaps pharmsci 360 2024: Flex manufacturing PharmTech.com15:18Cancer Treatment Pharma Cancer

Merck and Mestag enter inflammatory disease partnership worth up to $1.9bn PMLiVE12:51Pharma Biotechnology Global Health

Could summit Therapeutics become the next Merck? The Motley Fool12:49Pharma Biotechnology China

Tepmetko, Jemperli, and Neulasta pass cancer review panel to move closer to reimbursement Korea Biomedical Review07:07Cancer Health GSK

Merck partners with small UK biotech to drug fibroblasts for fibrosis, I&I diseases ENDPOINTS12:02Biotech Pharma Biotechnology

Merck's colorectal cancer therapy fails late-stage trial Yahoo! UK & Ireland12:03Pharma

Merck's lag-3 plus Keytruda combo fails Phase 3 in colorectal cancer ENDPOINTS12:29Pharma

Merck’s Keytruda approved by FDA as first-line malignant pleural mesothelioma treatment PMLiVE12:24Mumps Pharma

Merck's Keytruda Obtains its First FDA Approval for Mesothelioma Zacks14:35Mumps Pharma

Merck/Daiichi Sankyo’s ADC candidate shows promise in phase 3 lung cancer trial PMLiVE08:24Cancer Lung Cancer Pharma

Merck loses around $32B in 3 months: Time to sell the stock? Zacks14:01Pharma

Latest News

In the last half-hour

Geriatric Medicine Industry Assessment 2024-2030, Featuring Profiles of Key Players - Roche, Novartis, AbbVie, Johnson… GlobeNewswire (Press Release)09:31

In the last hour

German chip materials firm Merck opens new R&D center in S. Korea Yonhap News Agency09:01

Yesterday

February 2025 Options Now Available For Merck (MRK) Nasdaq15:53 9-Oct-24

$60.5 Billion Proteomics Industry Forecast Report, 2029, Featuring Strategic Analysis of 25 Key Players - Thermo Fisher … GlobeNewswire (Press Release)15:32 9-Oct-24

Merck Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland ... Merck Group (Press Release)13:05 9-Oct-24

MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA Business Wire (Press Release)13:04 9-Oct-24

Merck and Mestag enter inflammatory disease partnership worth up to $1.9bn PMLiVE12:51 9-Oct-24

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and… Business Wire (Press Release)11:47 9-Oct-24

MSD’s Phase III trial of head and neck cancer treatment meets primary endpoint Clinical Trials Arena11:40 9-Oct-24

In the last 7 days

Mestag’s activated fibroblast approach draws Merck in $1.9B deal BioWorld21:58 8-Oct-24

Phanes Therapeutics Announces First Patient Dosed in Clinical Study of PT886 in Combination… PR Newswire (Press Release)19:25 8-Oct-24

PTAB Institutes Eight More IPRs Filed by Merck on Johns Hopkins Pembrolizumab Patents JD Supra17:13 8-Oct-24

Merck & Co Buys Into Mestag's Fibroblast Approach To Treat Inflammation Scrip Pharma Intelligence16:29 8-Oct-24

Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease FiercePharma15:41 8-Oct-24

Merck & Co. signs $1.9B deal with Mestag to explore fibroblast therapies for inflammation FierceBiotech14:05 8-Oct-24

Merck partners with small UK biotech to drug fibroblasts for fibrosis, I&I diseases ENDPOINTS12:02 8-Oct-24

Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Event-Free Survival (EFS) as… Business Wire (Press Release)11:52 8-Oct-24

Flavonoids Market Report 2024-2032, with Profiles of Key Players Alchem, Bordas, Cayman Chemical, Extrasynthese, Flavon … GlobeNewswire (Press Release)09:30 8-Oct-24

Merck Immune For 'Inflated' Vax Claims To FDA, 3rd Circ. Says Law36002:02 8-Oct-24

Merck: Murky Is A Better Description - Strong Sell (Technical Analysis) Seeking Alpha00:46 8-Oct-24

Merck DEI Program Targeted by Edward Blum Group for EEOC Review Bloomberg Law22:23 7-Oct-24

Merck Escapes Antitrust Liability in Suit Over Its Mumps Vaccine Bloomberg Law20:05 7-Oct-24

Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight GlobeNewswire (Press Release)18:01 7-Oct-24

Merck Foundation Chief Executive Officer (CEO) & African First Ladies announced the Call for… African Press Organization10:04 7-Oct-24

Merck Is At Support And Should Go Higher (Technical Analysis) Seeking Alpha09:45 7-Oct-24

Is Summit Therapeutics a Millionaire Maker? The Motley Fool16:17 5-Oct-24

Protein Expression Market Global Report 2024, with Benchmarking of Key Players Agilent… Business Wire (Press Release)18:27 4-Oct-24

BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda FiercePharma16:01 4-Oct-24

Could Summit Therapeutics Become the Next Merck? The Motley Fool12:49 4-Oct-24

Tepmetko, Jemperli, and Neulasta pass cancer review panel to move closer to reimbursement Korea Biomedical Review07:07 4-Oct-24

ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA®… PR Newswire (Press Release)05:34 4-Oct-24

Merck stock edges lower as CMS alters negotiating process FXstreet20:33 3-Oct-24

In the last month

Sexy Science in Pharmaceuticals: Hot-Melt Extrusion PharmTech.com16:02 2-Oct-24

Merck Announces Remote Monitoring Technology SENSEHUB Cow Calf AgriMarketing08:07 2-Oct-24

Evaxion Biotech Partners with Merck for Vaccine Development TipRanks21:59 1-Oct-24

What’s it like moving back to Ireland after five years in Australia? Silicon Republic16:32 1-Oct-24

Assessment of Western Blotting Markets Through 2030, Featuring Strategic Analysis of Advansta, Bio-Rad Labs, LI-COR,… GlobeNewswire (Press Release)16:32 1-Oct-24

AAPS PharmSci 360 2024: Flex Manufacturing PharmTech.com15:18 1-Oct-24

Merck Foundation Chief Executive Officer (CEO) & African First Ladies Announced the Call for… African Press Organization12:47 1-Oct-24

Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon… Business Wire (Press Release)11:49 1-Oct-24

Merck to Hold Third-Quarter 2024 Sales and Earnings Conference Call Oct. 31 Business Wire (Press Release)11:31 1-Oct-24

Antibody Drugs Technologies and Global Market Report 2024, with Profiles of Leading Companies,… Business Wire (Press Release)17:30 30-Sept-24

Merck Foundation marking “World Heart Day” by providing out of 2080 scholarships, 830… African Press Organization09:27 30-Sept-24

Is Merck Stock a Buy? The Motley Fool11:36 29-Sept-24

3 Healthcare Stocks to Watch as the Aging Population Drives Demand Entrepreneur Magazine17:13 27-Sept-24

Merck & Co Takes A Punt On Evaxion’s AI Vaccines Scrip Pharma Intelligence15:48 27-Sept-24

Merck Insiders Sell US$11m Of Stock, Possibly Signalling Caution Simply Wall St15:30 27-Sept-24

FDA Panel Votes Didn’t Favor Merck’s Keytruda in Some Cases Bloomberg Law01:28 27-Sept-24

Merck, Evaxion expand collaboration with infectious disease vaccine pact ENDPOINTS13:03 26-Sept-24

Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end FierceBiotech12:33 26-Sept-24

Merck to Present New Long-Term Data for Tulisokibart (MK-7240), an Investigational Anti-TL1A… Business Wire (Press Release)11:55 26-Sept-24

Bioidentical Hormones Market Report 2024 with Competitive Analysis of Leasing Players, Pfizer, AbbVie, Bayer, Abbott… GlobeNewswire (Press Release)09:05 26-Sept-24

This Is What Whales Are Betting On Merck & Co Nasdaq22:50 25-Sept-24

Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3 FierceBiotech13:51 25-Sept-24

Merck's LAG-3 plus Keytruda combo fails Phase 3 in colorectal cancer ENDPOINTS12:29 25-Sept-24

Merck Reports Approval In Japan For Keytruda Regimen For Certain Patients With Nsclc RTT News12:10 25-Sept-24

Merck's colorectal cancer therapy fails late-stage trial Yahoo! UK & Ireland12:03 25-Sept-24

Merck’s KEYTRUDA® (pembrolizumab) Receives New Approvals in Japan for Certain Patients With… Business Wire (Press Release)11:30 25-Sept-24

Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only… Business Wire (Press Release)13:09 24-Sept-24

Merck presents RWE study of multiple sclerosis drug Mavenclad in Koreans Korea Biomedical Review05:49 24-Sept-24

Merck Foundation Chief Executive Officer (CEO) & African First Ladies announced the Call for… African Press Organization14:29 23-Sept-24

SEC settles insider charges related to Merck-Pandion merger BioWorld22:33 20-Sept-24

Claims Over Merck Osteoporosis Drug Fosamax Labeling Are Back on Bloomberg Law19:37 20-Sept-24

Germany Chemical Licensing Market Forecast 2024-2029, Featuring Mitsubishi Gas, ExxonMobil,… Business Wire (Press Release)17:03 20-Sept-24

Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA… FiercePharma15:28 20-Sept-24

Merck Loses Around $32B in 3 Months: Time to Sell the Stock? Zacks14:01 20-Sept-24

Merck Receives Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Regimens as Treatment… Business Wire (Press Release)12:38 20-Sept-24

Merck/Daiichi Sankyo’s ADC candidate shows promise in phase 3 lung cancer trial PMLiVE08:24 20-Sept-24

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms? Medpage Today06:32 20-Sept-24

Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial Seeking Alpha01:28 20-Sept-24

Merck's Keytruda Obtains its First FDA Approval for Mesothelioma Zacks14:35 19-Sept-24

Siemens and Merck Join Forces to Revolutionize Smart Manufacturing for a Sustainable Future Manufacturing Today14:16 19-Sept-24

Tanzania hosts 11th Merck Foundation Africa-Asia Luminary The Citizen, Tanzania12:44 19-Sept-24

Merck’s Keytruda approved by FDA as first-line malignant pleural mesothelioma treatment PMLiVE12:24 19-Sept-24

Study: Merck and Daiichi's Lung Cancer Treatment Shows Promise Zacks19:35 18-Sept-24

Merck Foundation Africa Asia Luminary 2024 to be conducted under the patronage of Tanzania… African Press Organization18:35 18-Sept-24

PictorLabs Raises $30 Million in Series B Funding to Accelerate AI-Powered Virtual Staining… PR Newswire (Press Release)14:06 18-Sept-24

Merck Foundation Chief Executive Officer (CEO) & African First Ladies announced the Call for… African Press Organization13:10 18-Sept-24

Merck presents positive phase 3 results for Keytruda regimen in early-stage breast cancer PMLiVE12:30 18-Sept-24

Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of… GlobeNewswire (Press Release)09:22 18-Sept-24

Merck Animal Health Partners With The American Assn Of Bovine Practitioners Foundation To Award Scholarships AgriMarketing08:14 18-Sept-24

Merck Animal Health Recognizes Dr. Robert B. Cherenson With Lander Veterinary Clinic, Inc. As Mentor Of The Year AgriMarketing08:04 18-Sept-24

FDA Approves Merck’s Keytruda in Mesothelioma Treatment Bloomberg Law02:48 18-Sept-24

Merck/Daiichi Beef Up Regulatory Position For HER3 ADC Scrip Pharma Intelligence23:51 17-Sept-24

Merck could see double-digit stock price increases in next 5 years: Jacob Sonenshine Fox News17:20 17-Sept-24

Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data FierceBiotech12:41 17-Sept-24

Merck and Daiichi’s rejected HER3 ADC clears a Phase 3 in certain lung cancers ENDPOINTS12:21 17-Sept-24

Siemens and Merck hook up on smart manufacturing Electronics Weekly06:27 17-Sept-24

LENVIMA(R) (lenvatinib) Plus KEYTRUDA(R) (pembrolizumab) in Combination With Transarterial… JCN Newswire04:07 17-Sept-24

Amgen and Merck become first industry partners of academic clinical trial diversity initiative FierceBiotech20:24 16-Sept-24

#ESMO24: Merck's Eliav Barr on subcutaneous Keytruda, Summit's data, 'fetch me that drug' and more ENDPOINTS14:08 16-Sept-24

Merck and Siemens enter Strategic Partnership on Digital Transformation Technology Merck Group (Press Release)13:07 16-Sept-24

Merck shares positive ten-year results for Keytruda in advanced melanoma PMLiVE12:28 16-Sept-24

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone… Business Wire (Press Release)12:15 16-Sept-24

BeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in… GlobeNewswire (Press Release)12:11 16-Sept-24

Merck launches single-use reactor designed to accelerate antibody drug conjugate manufacturing Manufacturing Chemist12:10 16-Sept-24

Merck’s (MRK) Keytruda Expands Women’s Cancer Treatment Options TipRanks08:11 16-Sept-24

Merck’s Top-Seller Cements Status in Hard-to-Treat Breast Cancer BNN Bloomberg16:14 15-Sept-24

KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as Single Agent After… Business Wire (Press Release)15:30 15-Sept-24

Ten-Year Data for Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Sustained Overall Survival… Business Wire (Press Release)13:49 15-Sept-24

ESMO: With survival win, Merck's Keytruda redeems itself in early triple-negative breast cancer FiercePharma13:12 15-Sept-24

ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in… FiercePharma15:42 14-Sept-24

Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Reduced Risk of Death by 33%… Business Wire (Press Release)15:39 14-Sept-24

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial… Business Wire (Press Release)15:36 14-Sept-24

#ESMO24: Bristol Myers touts LAG-3 strategy in lung cancer as it preps for showdown with Merck’s Keytruda ENDPOINTS12:59 14-Sept-24

Merck Appears Ready To Return To June Highs (Technical Analysis) Seeking Alpha12:37 14-Sept-24

Where Will Merck Stock Be in 5 Years? The Motley Fool12:19 14-Sept-24

IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head… GlobeNewswire (Press Release)07:34 14-Sept-24

ESMO: Merck unpacks a mixed bag of gynecological cancer results for Keytruda FiercePharma23:06 13-Sept-24

These 10 NJ Companies Are Among America’s Best Employers Patch18:47 13-Sept-24

ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival FiercePharma13:17 13-Sept-24

EZH2 Inhibitors Market Set to Register Strong Growth Momentum at 25.85% CAGR by 2030 | Epizyme… Industry Today12:21 13-Sept-24

Cytovation to present full safety and efficacy data from the CICILIA Phase I/IIa trial evaluating CY-101 in solid… GlobeNewswire (Press Release)08:03 13-Sept-24

Equitable Breakthroughs in Medicine Development (EQBMED) to work with Inaugural Sponsor… PR Newswire (Press Release)14:01 12-Sept-24

Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits ... Merck Group (Press Release)13:53 12-Sept-24

view more headlines

10 Oct 09:31

Merck & Co News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Merck & Co news, covering the latest MSD share price, Merck Sharp & Dohme company announcements, product trials, pharmaceutical news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.